Joel C. Marrs, PharmD, FASHP, FCCP, FNLA, BCPS-AQ Cardiology, BCACP, CLS, ASH-CHC

home / authors / joel-c-marrs-pharmd-fashp-fccp-fnla-bcps-aq-cardiology-bcacp-cls-ash-chc

Articles

The Impact of PCSK9 Inhibition in Dyslipidemia Management

The Impact of PCSK9 Inhibition in Dyslipidemia Management

April 24th 2017

This Continuing Education activity is supported by an educational grant from Amgen.

Read More

© 2024 MJH Life Sciences

All rights reserved.